An Acetylcholinesterase Inhibitor from the Leaves of Securinega suffruticosa
![]() |
Jang, Choon-Hee
(College of Pharmacy, Woosuk University)
Eun, Jae-Soon (College of Pharmacy, Woosuk University) Park, Hye-Won (College of Pharmacy, Woosuk University) Seo, Seon-Mi (College of Pharmacy, Woosuk University) Yang, Jae-Heon (College of Pharmacy, Woosuk University) Leem, Kang-Hyun (College of Pharmacy, Woosuk University) Oh, Seok-Heung (College of Science and Technology, Woosuk University) Oh, Chan-Ho (College of Science and Technology, Woosuk University) Baek, Nam-In (Department of Life Science, Kyung-Hee University) Kim, Dae-Keun (College of Pharmacy, Woosuk University) |
1 | Polinsky, R. J. (1998) Clinical pharmacology of rivastigmine: a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Clin. Ther. 20: 634-647 DOI PUBMED ScienceOn |
2 | Ellman, G. L., Courtney, K. D., Andres, V and Featherstone, R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 68-75 |
3 | Rieger, F., Shelanski, M. L. and Greene, L. A. (1980) The effects of nerve growth factor on acetylcholinesterase and its multiple forms in cultures of rat PC12 pheochromocytoma cells: increased total specific activity and appearance of the 16 S molecular form. Dev. BioI. 76: 238-43 DOI ScienceOn |
4 | Beutler, J. A and Livant, L. (1984) CMR assignments of the securinine alkaloids. J. Nat. Prado 47: 677-681 DOI |
5 | Aarsland, D., Larsen, J. P.,Reinvang, I. and Aarsland, A M. (1994) Effects of cholinergic blockade on language in healthy young women. Brain, 117: 1377-1384 DOI ScienceOn |
6 | Brufani, M. and Filocamo, L. (1996) Rational design new acetylcholinesterase inhibitors: In Becker, R., and Giacobini, E. (eds.), Alzheimer disease: from molecular biology to therapy, 171-177, Birkhauster, Boston |
7 | Hwang, S. Y., Chang, Y. P.,Byun, S. J., Jeon, M. H. and Kim, Y C. (1996) An acetylcholinesterase inhibitor isolated from Corydalis Tuber and its mode of action. Kor. J. Pharmacogn. 27: 91-95 |
8 | 蕭培植(1994) 中國本草圖鑑(第1券 ), 63. 麗江出版社, 서울 |
9 | Cohen, S. G., Chishti, S. B., Bell, D. A, Howard, S. I., Salih, E. and Cohen, J. B. (1991) General occurrence of binding to acetylcholinesterase-substrate complex in noncompetitive inhibition and in inhibition by substrate. Biochim Biophys Acta. 1076: 112-122 DOI ScienceOn |
10 | Cummings, J. L. and Back, C. (1998) The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. Am. J. Geriatr. Psychiatry 6: 64-78 DOI |
11 | Hachiski, V. C., Miff, L. D., Zikhka, E., Du boulay, G H., McAllister, V. L., Marshall, J., Russel, R W. R and Symon, L. (1975) Cerebral blood flow in dementia. Arch. Neural. 32: 632-637 DOI ScienceOn |
12 | Webster, R. A. and Jordan, C. C. (1989) Neurotransmitters, Drugs and Disease, 428-445. Blacewell scienific publication, London |
13 | 李昌福(1989) 大韓植物圖鑑, 508. 鄕文社, 서울 |
14 | Snieckus, V. (1973) The securinega alkaloids. In Manske, R. H. F. (ed.), The alkaloids-Chemistry and physiology, vol. XIV: 425-506. Academic Press. New York |
![]() |